A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Clinical trial NCT04909801 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04909801
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2023-06-14
- Enrollment
- 338
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.